MIAMI, May 20, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with […]
Quarterly net revenues were RMB359.1 million (US$49.7 million)1Quarterly lidar shipments were 59,101 units SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) […]